Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1748* | 2021 |
BTS guidelines for the management of spontaneous pneumothorax M Henry, T Arnold, J Harvey Thorax 58 (Suppl 2), ii39, 2003 | 972 | 2003 |
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
Nontuberculous mycobacteria in non‐HIV patients: epidemiology, treatment and response MT Henry, L Inamdar, D O'riordain, M Schweiger, JP Watson European Respiratory Journal 23 (5), 741-746, 2004 | 247 | 2004 |
Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis I Rahman, E Skwarska, M Henry, M Davis, CM O’Connor, MX FitzGerald, ... Free Radical Biology and Medicine 27 (1-2), 60-68, 1999 | 225 | 1999 |
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study TM Drake, AB Docherty, EM Harrison, JK Quint, H Adamali, S Agnew, ... American journal of respiratory and critical care medicine 202 (12), 1656-1665, 2020 | 221 | 2020 |
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF MT Henry, K McMahon, AJ Mackarel, K Prikk, T Sorsa, P Maisi, R Sepper, ... European Respiratory Journal 20 (5), 1220-1227, 2002 | 207 | 2002 |
Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? I Rahman, E Swarska, M Henry, J Stolk, W MacNee Thorax 55 (3), 189-193, 2000 | 201 | 2000 |
A polymorphism in the tumor necrosis factor-α gene promoter region may predispose to a poor prognosis in COPD VM Keatings, SJ Cave, MJ Henry, K Morgan, CM O'Connor, ... Chest 118 (4), 971-975, 2000 | 178 | 2000 |
Efficacy and complications of small-bore, wire-guided chest drains A Horsley, L Jones, J White, M Henry Chest 130 (6), 1857-1863, 2006 | 167 | 2006 |
Efficacy of thrombolytic agents in the treatment of pulmonary embolism T Capstick, MT Henry European Respiratory Journal 26 (5), 864-874, 2005 | 129 | 2005 |
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis HMT Camille Moore, Rachel Z. Blumhagen, Ivana V.Yang, Avram Walts, Julie ... Am J Respir Crit Care Med. 200 (2), 199-208, 2019 | 104 | 2019 |
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study. et al Cottin V, Koschel D, Günther A ERJ open research 4, 2018 | 91 | 2018 |
A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD S Nair, E Thomas, SB Pearson, MT Henry Chest 128 (1), 48-54, 2005 | 69 | 2005 |
26. A Randomized Controlled Trial to Assess the Optimal Dose and Effect of Nebulized Albuterol in Acute Exacerbations of COPD HMT Nair S, Thomas E, Pearson SB chest, 2005 | 69 | 2005 |
Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis KJ Russell, J McREDMOND, N Mukherji, C Costello, V Keatings, ... American journal of respiratory and critical care medicine 157 (3), 756-761, 1998 | 69 | 1998 |
A study to assess inhaler technique and its potential impact on asthma control in patients attending an asthma clinic MDM Harnett CM1, Hunt EB, Bowen BR, O'Connell OJ, Edgeworth DM, Mitchell P ... j asthma 51 (4), 440-445, 2014 | 67 | 2014 |
Microalbuminuria in patients with non-insulin-dependent diabetes mellitus relates to nocturnal systolic blood pressure TH Mitchell, B Nolan, M Henry, C Cronin, H Baker, G Greely The American journal of medicine 102 (6), 531-535, 1997 | 67 | 1997 |
An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis MT Henry, S Cave, J Rendall, CM O'Connor, K Morgan, MX FitzGerald, ... European Journal of Human Genetics 9 (4), 273-278, 2001 | 64 | 2001 |
Radiological Characteristics, Histological Features and Clinical Outcomes of Lung Cancer Patients with Coexistent Idiopathic Pulmonary Fibrosis MB Khan KA, Kennedy MP, Moore E, Crush L, Prendeville S, ... lung 193 (1), 71-77, 2015 | 62 | 2015 |